1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Active Pharmaceutical Ingredients Global Market Outlook - Trends, Forecast, and Opportunity Assessment (2014-2022)

The Global Active Pharmaceutical Ingredients (API) market accounted for $121.4 billion in 2014 and is expected to grow at a CAGR of 6.4% to reach $198.8 billion by 2022. Patent expiration of prominent drugs, government initiatives, regional penetration, increasing aged population are some of the factors that are driving the market growth. Strict validation and safety guidelines stated by WHO and fragmented market are the factors that are hampering the API market growth.

The Global Active Pharmaceutical Ingredients (API) market is segmented on the basis of type of API, manufacturers, therapeutic area and geography. On the basis of type of API, the active pharmaceutical ingredients market is segmented into synthetic chemical API and biological API. By type of manufacturers, the market is categorized into captive (or in-house) and contract manufacturing. By therapeutic applications, the market is segmented into oncology, anti-Infectives, cardiovascular and hematopoietic system, gastrointestinal disorder, hormonal-related disorder, metabolic disorder, musculo-skeletal disorder and others. Anti-infectives application commanded the largest market share in 2014, whereas oncology is expected to be the fastest growing application with a CAGR of more than 8.8 during the forecast period.

By geography, it is segmented into North America, Europe, Asia Pacific and Rest of the World. North America is the global leader in the active pharmaceuticals ingredients market due to its highly developed research and development projects in the field of therapies, medical sciences, and drugs. Asia Pacific is projected to be the fastest growing regional market with a CAGR of more than 8%. The fast growth is attributed to patent expirations of drugs, and favourable investments in medical research.

Some of the prominent players in the active pharmaceutical ingredients (API) market include WuXi Apptec, Teva Pharmaceutical, Pfizer, Novartis, Mylan, BASF, Actavis, Cambrex, Dr. Reddy’s Laboratories and Novartis.

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Table Of Contents

Active Pharmaceutical Ingredients Global Market Outlook - Trends, Forecast, and Opportunity Assessment (2014-2022)
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Active Pharmaceutical Ingredients Market, By Types of API
5.1 Introduction
5.2 Synthetic chemical API
5.2.1 Branded/ Innovative
5.2.2 Generic/Non- Branded
5.3 Biological API
5.3.1 Biotech
5.3.2 Biosimilar
5.4 High potency active pharmaceutical ingredients(HPAPI)

6 Global Active Pharmaceutical Ingredients Market, By Type of manufacturing
6.1 Introduction
6.2 Captive (or in-house) manufacturing
6.3 Contract manufacturing

7 Global Active Pharmaceutical Ingredients Market, By Therapeutic applications
7.1 Introduction
7.2 Oncology
7.3 Anti-Infectives
7.4 Cardiovascular and hematopoietic system
7.5 Gastrointestinal disorder
7.6 Hormonal-related disorder
7.7 Metabolic disorder
7.8 Musculo-skeletal disorder

8 Global Active Pharmaceutical Ingredients Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia
8.4 Rest of the World
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others


9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions and Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Zoetis (U.S.)
10.2 Merck Animal Health (U.S.)
10.3 Merial Inc. (Sanofi) (France)
10.4 Elanco Animal Health (U.S.)
10.5 Boehringer Ingelheim (Germany)
10.6 Bayer Healthcare (Germany)
10.7 Bioniche Animal Health (Canada)
10.8 Heska Co. (U.S.)
10.9 Ceva Animal Health, Inc.
10.10 Virbac

List of Tables
1 Global Active Pharmaceutical Ingredients Market Outlook, By Types of API (2012-2022) ($MN)
2 Global Active Pharmaceutical Ingredients Market Outlook, By Synthetic chemical API (2012-2022) ($MN)
3 Global Active Pharmaceutical Ingredients Market Outlook, By Branded/ Innovative (2012-2022) ($MN)
4 Global Active Pharmaceutical Ingredients Market Outlook, By Generic/Non- Branded (2012-2022) ($MN)
5 Global Active Pharmaceutical Ingredients Market Outlook, By Biological API (2012-2022) ($MN)
6 Global Active Pharmaceutical Ingredients Market Outlook, By Biotech (2012-2022) ($MN)
7 Global Active Pharmaceutical Ingredients Market Outlook, By Biosimilar (2012-2022) ($MN)
8 Global Active Pharmaceutical Ingredients Market Outlook, By High potency active pharmaceutical ingredients(HPAPI) (2012-2022) ($MN)
9 Global Active Pharmaceutical Ingredients Market Outlook, By Type of manufacturing (2012-2022) ($MN)
10 Global Active Pharmaceutical Ingredients Market Outlook, By Captive (or in-house) manufacturing (2012-2022) ($MN)
11 Global Active Pharmaceutical Ingredients Market Outlook, By Contract manufacturing (2012-2022) ($MN)
12 Global Active Pharmaceutical Ingredients Market Outlook, By Therapeutic applications (2012-2022) ($MN)
13 Global Active Pharmaceutical Ingredients Market Outlook, By Oncology (2012-2022) ($MN)
14 Global Active Pharmaceutical Ingredients Market Outlook, By Anti-Infectives (2012-2022) ($MN)
15 Global Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular and hematopoietic system (2012-2022) ($MN)
16 Global Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal disorder (2012-2022) ($MN)
17 Global Active Pharmaceutical Ingredients Market Outlook, By Hormonal-related disorder (2012-2022) ($MN)
18 Global Active Pharmaceutical Ingredients Market Outlook, By Metabolic disorder (2012-2022) ($MN)
19 Global Active Pharmaceutical Ingredients Market Outlook, By Musculo-skeletal disorder (2012-2022) ($MN)
20 North America Active Pharmaceutical Ingredients Market Outlook, By Types of API (2012-2022) ($MN)
21 North America Active Pharmaceutical Ingredients Market Outlook, By Synthetic chemical API (2012-2022) ($MN)
22 North America Active Pharmaceutical Ingredients Market Outlook, By Branded/ Innovative (2012-2022) ($MN)
23 North America Active Pharmaceutical Ingredients Market Outlook, By Generic/Non- Branded (2012-2022) ($MN)
24 North America Active Pharmaceutical Ingredients Market Outlook, By Biological API (2012-2022) ($MN)
25 North America Active Pharmaceutical Ingredients Market Outlook, By Biotech (2012-2022) ($MN)
26 North America Active Pharmaceutical Ingredients Market Outlook, By Biosimilar (2012-2022) ($MN)
27 North America Active Pharmaceutical Ingredients Market Outlook, By High potency active pharmaceutical ingredients(HPAPI) (2012-2022) ($MN)
28 North America Active Pharmaceutical Ingredients Market Outlook, By Type of manufacturing (2012-2022) ($MN)
29 North America Active Pharmaceutical Ingredients Market Outlook, By Captive (or in-house) manufacturing (2012-2022) ($MN)
30 North America Active Pharmaceutical Ingredients Market Outlook, By Contract manufacturing (2012-2022) ($MN)
31 North America Active Pharmaceutical Ingredients Market Outlook, By Therapeutic applications (2012-2022) ($MN)
32 North America Active Pharmaceutical Ingredients Market Outlook, By Oncology (2012-2022) ($MN)
33 North America Active Pharmaceutical Ingredients Market Outlook, By Anti-Infectives (2012-2022) ($MN)
34 North America Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular and hematopoietic system (2012-2022) ($MN)
35 North America Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal disorder (2012-2022) ($MN)
36 North America Active Pharmaceutical Ingredients Market Outlook, By Hormonal-related disorder (2012-2022) ($MN)
37 North America Active Pharmaceutical Ingredients Market Outlook, By Metabolic disorder (2012-2022) ($MN)
38 North America Active Pharmaceutical Ingredients Market Outlook, By Musculo-skeletal disorder (2012-2022) ($MN)
39 Europe Active Pharmaceutical Ingredients Market Outlook, By Types of API (2012-2022) ($MN)
40 Europe Active Pharmaceutical Ingredients Market Outlook, By Synthetic chemical API (2012-2022) ($MN)
41 Europe Active Pharmaceutical Ingredients Market Outlook, By Branded/ Innovative (2012-2022) ($MN)
42 Europe Active Pharmaceutical Ingredients Market Outlook, By Generic/Non- Branded (2012-2022) ($MN)
43 Europe Active Pharmaceutical Ingredients Market Outlook, By Biological API (2012-2022) ($MN)
44 Europe Active Pharmaceutical Ingredients Market Outlook, By Biotech (2012-2022) ($MN)
45 Europe Active Pharmaceutical Ingredients Market Outlook, By Biosimilar (2012-2022) ($MN)
46 Europe Active Pharmaceutical Ingredients Market Outlook, By High potency active pharmaceutical ingredients(HPAPI) (2012-2022) ($MN)
47 Europe Active Pharmaceutical Ingredients Market Outlook, By Type of manufacturing (2012-2022) ($MN)
48 Europe Active Pharmaceutical Ingredients Market Outlook, By Captive (or in-house) manufacturing (2012-2022) ($MN)
49 Europe Active Pharmaceutical Ingredients Market Outlook, By Contract manufacturing (2012-2022) ($MN)
50 Europe Active Pharmaceutical Ingredients Market Outlook, By Therapeutic applications (2012-2022) ($MN)
51 Europe Active Pharmaceutical Ingredients Market Outlook, By Oncology (2012-2022) ($MN)
52 Europe Active Pharmaceutical Ingredients Market Outlook, By Anti-Infectives (2012-2022) ($MN)
53 Europe Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular and hematopoietic system (2012-2022) ($MN)
54 Europe Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal disorder (2012-2022) ($MN)
55 Europe Active Pharmaceutical Ingredients Market Outlook, By Hormonal-related disorder (2012-2022) ($MN)
56 Europe Active Pharmaceutical Ingredients Market Outlook, By Metabolic disorder (2012-2022) ($MN)
57 Europe Active Pharmaceutical Ingredients Market Outlook, By Musculo-skeletal disorder (2012-2022) ($MN)
58 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Types of API (2012-2022) ($MN)
59 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Synthetic chemical API (2012-2022) ($MN)
60 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Branded/ Innovative (2012-2022) ($MN)
61 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Generic/Non- Branded (2012-2022) ($MN)
62 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Biological API (2012-2022) ($MN)
63 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Biotech (2012-2022) ($MN)
64 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Biosimilar (2012-2022) ($MN)
65 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By High potency active pharmaceutical ingredients(HPAPI) (2012-2022) ($MN)
66 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Type of manufacturing (2012-2022) ($MN)
67 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Captive (or in-house) manufacturing (2012-2022) ($MN)
68 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Contract manufacturing (2012-2022) ($MN)
69 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Therapeutic applications (2012-2022) ($MN)
70 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Oncology (2012-2022) ($MN)
71 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Anti-Infectives (2012-2022) ($MN)
72 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular and hematopoietic system (2012-2022) ($MN)
73 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal disorder (2012-2022) ($MN)
74 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Hormonal-related disorder (2012-2022) ($MN)
75 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Metabolic disorder (2012-2022) ($MN)
76 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Musculo-skeletal disorder (2012-2022) ($MN)
77 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Types of API (2012-2022) ($MN)
78 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Synthetic chemical API (2012-2022) ($MN)
79 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Branded/ Innovative (2012-2022) ($MN)
80 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Generic/Non- Branded (2012-2022) ($MN)
81 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Biological API (2012-2022) ($MN)
82 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Biotech (2012-2022) ($MN)
83 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Biosimilar (2012-2022) ($MN)
84 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By High potency active pharmaceutical ingredients(HPAPI) (2012-2022) ($MN)
85 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Type of manufacturing (2012-2022) ($MN)
86 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Captive (or in-house) manufacturing (2012-2022) ($MN)
87 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Contract manufacturing (2012-2022) ($MN)
88 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Therapeutic applications (2012-2022) ($MN)
89 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Oncology (2012-2022) ($MN)
90 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Anti-Infectives (2012-2022) ($MN)
91 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular and hematopoietic system (2012-2022) ($MN)
92 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal disorder (2012-2022) ($MN)
93 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Hormonal-related disorder (2012-2022) ($MN)
94 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Metabolic disorder (2012-2022) ($MN)
95 Rest of the World Active Pharmaceutical Ingredients Market Outlook, By Musculo-skeletal disorder (2012-2022) ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.